Redenlab partners with BDCRC to support new NIH-funded Batten disease research
A newly formed research network focused on Batten disease, a rare and inherited brain disorder that primarily affects…
Language
Latest content
Redenlab’s Chief Science Officer, Adam P. Vogel, PhD, leads groundbreaking study on speech analysis for neurodegenerative diseases
MEDIA RELEASE Melbourne, 19 January 2024 — Redenlab, a leader in innovative healthcare solutions, ispleased to announce a…
Childhood apraxia of speech clinical trial
Speech disorders impacting children have debilitating impacts on educational, social and later employment outcomes. There are limited therapeutic…
Researchers working towards finding a new treatment for Spinocerebellar Ataxia Type 1 (SCA1)
Spinocerebellar ataxia Type 1 (SCA1) is a dominantly inherited neurodegenerative disease resulting in balance, speech, thinking and coordination…
The FA App
Friedreich ataxia (FA) is a progressive, genetically inherited multisystem disease that affects children and adults. FA leads to…
TRACK-FA Study
Friedreich ataxia (FA) is an inherited, multisystem neurodegenerative disease that results in profound changes to speech, swallowing, balance,…
Professor Angela Morgan leads the Translational Centre for Speech Disorders in groundbreaking NHMRC CRE research program
Redenlab, a leading provider of innovative solutions in the field of pediatric and neurodevelopment communication, proudly announces that…
Academic and patient advocacy group collaborations in Dentatorubral-pallidoluysian atrophy (DRPLA)
Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare progressive brain disorder that can impact children and adults. In children, DRPLA…
Redenlab shines in Huberman Podcast, unveiling cannabis study and speech analysis expertise
MEDIA RELEASERedenlab, a leading techbio company, proudly announces its recent feature on the highly acclaimed Huberman Podcast. The…
Temporary Assessment of Language in Kabuki Syndrome (TALK) Study
Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate…
ARIAS: Zooming in on eye-based biomarkers for Alzheimer’s
Scientists are turning to retinas as a potential screening target for early signs of Alzheimer’s, an incurable neurodegenerative…
Redenlab strengthens its reach in linguistic/language analytics with appointment of eminent neuroscientist Prof Adolfo Garcia
Dr Garcia joins the Redenlab science team to drive its language analytics pipeline for cognitive-linguistic disorders like fronto-temporal…
Redenlab working as industry partner supporting a successful Australian Research Council Training Centre for Optimal Ageing
Redenlab are part of a successful consortium securing funding for training a new cohort of early career researchers…
